AB or CNS: Which Is the Better Value Stock Right Now?

Zacks research identifies AllianceBernstein (AB) as a superior value investment compared to Cohen & Steers Inc (CNS) within the Financial - Investment Management sector. AB holds a Zacks Rank of #2 (Buy) against CNS's #3 (Hold), and presents more attractive valuation metrics, including a forward P/E of 12.76 versus CNS's 25.95, a PEG ratio of 1.64 versus 2.55, and a P/B ratio of 2.31 versus 7.61. These factors contribute to AB receiving a 'B' Zacks Value grade while CNS received an 'F', indicating AB offers a better value opportunity for investors.

Analysis

Within the Financial - Investment Management sector, a comparative value analysis strongly positions AllianceBernstein (AB) over Cohen & Steers Inc (CNS). This conclusion is supported by the Zacks Rank system, which assigns AB a #2 (Buy) rating, indicating positive earnings estimate revision trends, compared to CNS's #3 (Hold) rating. The valuation disparity is significant across key metrics: AB trades at a forward P/E of 12.76, less than half of CNS's 25.95. Furthermore, AB's PEG ratio of 1.64 is considerably more attractive than CNS's 2.55, suggesting a more reasonable price relative to its expected earnings growth. The gap is also evident in the price-to-book ratio, where AB's 2.31 stands in stark contrast to CNS's 7.61. These quantitative factors culminate in AB achieving a 'B' grade for Value from Zacks, while CNS receives an 'F', reinforcing the assessment that AB presents a superior value proposition at current levels.

Key Decisions for Investors

• Value-focused investors should consider AllianceBernstein (AB) as a more compelling opportunity than Cohen & Steers (CNS) due to its stronger earnings estimate momentum and significantly more attractive valuation multiples.
• Investors holding or evaluating Cohen & Steers (CNS) should be cautious of its high valuation, reflected in its forward P/E of 25.95 and P/B of 7.61, which contribute to its 'F' grade for value.
• Given the analysis hinges on the Zacks Rank, which is driven by earnings estimate revisions, it is crucial to monitor for any changes in analyst estimates for both companies as this could alter the relative valuation argument.